- €1.94m
- €1.98m
- €0.64m
- 51
- 14
- 35
- 22
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.221 | 0.28 | 0.312 | 0.375 | 0.638 |
Cost of Revenue | |||||
Gross Profit | 0.148 | 0.233 | 0.277 | 0.316 | 0.412 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.367 | 0.165 | 0.202 | 0.261 | 0.722 |
Operating Profit | -0.146 | 0.115 | 0.11 | 0.113 | -0.084 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.15 | 0.104 | 0.098 | 0.103 | -0.093 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.181 | 0.102 | 0.093 | 0.06 | -0.101 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.181 | 0.102 | 0.093 | 0.06 | -0.101 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.181 | 0.102 | 0.093 | 0.06 | -0.101 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.211 | 0.119 | 0.108 | 0.07 | -0.118 |
Dividends per Share |